A systematic review of the cost-effectiveness of community and population interventions to reduce the modifiable risk factors for dementia.


Journal

Maturitas
ISSN: 1873-4111
Titre abrégé: Maturitas
Pays: Ireland
ID NLM: 7807333

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 09 05 2022
revised: 03 08 2022
accepted: 04 09 2022
medline: 23 10 2023
pubmed: 24 9 2022
entrez: 23 9 2022
Statut: ppublish

Résumé

Dementia is a leading global cause of morbidity and mortality. Evidence suggests that tackling modifiable lifecourse risk factors could prevent or delay a significant proportion of cases. Population- and community-based approaches change societal conditions such that everyone across a given community is more likely to live more healthily. We systematically reviewed economic studies of population- and community-based interventions to reduce modifiable lifecourse risk factors for dementia. We searched Medline, EMBASE, Web of Science, CINAHL, PsycInfo, Scopus, Econlit, ERIC, the British Education Index, and Google, on 03/03/2022. We included cost-effectiveness, cost-benefit, and cost-utility studies, provided that the direct outcome of the intervention was a modifiable risk factor for dementia, and was measured empirically. Quality appraisal was completed using the Consensus on Health Economic Criteria checklist. A narrative synthesis was performed. We included 45 studies, from 22,749 records identified. Included studies targeted smoking (n = 15), education (n = 10), physical inactivity (n = 9), obesity (n = 5), air pollution (n = 2), traumatic brain injury (n = 1), and multiple risk factors (n = 3). Intervention designs included changing the physical/food environment (n = 13), mass media programmes (n = 11), reducing financial barriers or increasing resources (n = 10), whole-community approaches (n = 6), and legislative change (n = 3). Overall, interventions were highly cost-effective and/or cost-saving, particularly those targeting smoking, educational attainment, and physical inactivity. Effects were observed in high- (e.g. USA and UK) and low- and middle-income (e.g. Mexico, Tanzania, Thailand) countries. Further research into the direct effects of targeting these risk factors on future dementia prevalence will have important economic, social and policy implications.

Identifiants

pubmed: 36150253
pii: S0378-5122(22)00197-9
doi: 10.1016/j.maturitas.2022.09.002
pii:
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104-116

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest KA received a speaker honorarium from Nutricia in 2021. All other authors declare no interests.

Auteurs

Sebastian Walsh (S)

Cambridge Public Health, University of Public Health, Robinson Way, Cambridge CB2 0SR, United Kingdom of Great Britain and Northern Ireland. Electronic address: Sjw261@medschl.cam.ac.uk.

Jacob Brain (J)

Institute of Mental Health, Jubilee Campus, University of Nottingham Innovation Park, Triumph Road, Nottingham NG7 2TU, United Kingdom of Great Britain and Northern Ireland.

Naaheed Mukadam (N)

Division of Psychiatry, University College London, Maple House, London W1T 7BN, United Kingdom of Great Britain and Northern Ireland.

Robert Anderson (R)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Woodstock Road, Oxford OX2 6GG, United Kingdom of Great Britain and Northern Ireland.

Leanne Greene (L)

College of Medicine and Health, University of Exeter, Exeter EX1 2HZ, United Kingdom of Great Britain and Northern Ireland.

Ishtar Govia (I)

Epidemiology Research Unit, Caribbean Institute for Health Research, The University of the West Indies, Mona Campus, Kingston 7, Jamaica.

Isla Kuhn (I)

University of Cambridge Medical School Library, School of Clinical Medicine, Cambridge CB2 0SP, United Kingdom of Great Britain and Northern Ireland.

Kaarin J Anstey (KJ)

UNSW Ageing Futures Institute, University of New South Wales, Kensington, Sydney 2033, Australia; Neuroscience Research Australia, 139 Barker Street, Randwick, NSW 2031, Australia.

Martin Knapp (M)

London School of Economics and Political Science, Houghton Street, London WC2A 2AE, United Kingdom of Great Britain and Northern Ireland.

Blossom C M Stephan (BCM)

Institute of Mental Health, Jubilee Campus, University of Nottingham Innovation Park, Triumph Road, Nottingham NG7 2TU, United Kingdom of Great Britain and Northern Ireland.

Carol Brayne (C)

Cambridge Public Health, University of Public Health, Robinson Way, Cambridge CB2 0SR, United Kingdom of Great Britain and Northern Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH